Innovation to Impact: Drug Development, AI, and Regulatory Strategy
De-Risking What Matters
· 37 min · Sezon 2 Odcinek 2
Notatki do odcinka
In this episode of Innovation to Impact: Ruminations & Ramblings, Szczepan Baran, Brian Berridge, and Nick Kelley tackle one of the biggest problems in modern drug development: we keep adding more technology, more data, and more complexity, yet clinical attrition remains painfully high. Across discussions on AI, NAMs, digital biomarkers, animal models, translational science, and organizational culture, they argue that innovation fails when tools become the strategy instead of serving clearly defined patient-centered decisions. The conversation explores why reverse translation matters, how AI…
Strona: share.transistor.fm
